Remix Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
100 Forge Rd Ste 400, Watertown, Massach...Phone Number
(781) 827-0901Website
www.remixtx.comRevenue
$13.5 MillionIndustry
About Remix Therapeutics
Remix Therapeutics is a clinical-stage biotechnology company focused on developing small molecule therapies that modulate RNA processing to address disease drivers at their origin. Their lead program, REM-422, is an investigational mRNA degrader targeting the MYB transcription factor, which is implicated in various cancers. The company aims to provide new therapeutic options for patients with high unmet medical needs, particularly in oncology. Founded in 2020, Remix is committed to scientific integrity and urgency in delivering innovative treatments.Explore more
Remix Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Remix Therapeutics
Compare insights from companies similar to Remix Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Remix Therapeutics Tech Stack
A closer look at the technologies used by Remix Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Remix Therapeutics
Sign Up For FreeTo access detailed company insights
Remix Therapeutics is a clinical-stage biotechnology company focused on developing small molecule therapies that modulate RNA processing to address disease drivers at their origin. Their lead program, REM-422, is an investigational mRNA degrader targeting the MYB transcription factor, which is implicated in various cancers. The company aims to prov... Read More
